Experimental gerontologyJul 31, 2026

Using n-acetylcysteine to reduce cell aging in human blood vessel cells through the HuR pathway

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Aug 3, 2026

Abstract

N-acetylcysteine (NAC) treatment significantly decreased reactive oxygen species (ROS) and p21 levels in senescent human umbilical vein endothelial cells (HUVECs).

Cellular senescence contributes to chronic inflammation and age-related diseases.
Late-passage HUVECs displayed characteristics of senescence, including increased SA-β-galactosidase activity and elevated ROS levels.
There was a progressive decline in the expression of the RNA-binding protein HuR from early to late passages.
NAC treatment restored HuR expression and reduced levels of inflammatory markers IL-6 and TNF-α.
The findings indicate that the decline of the HuR-protective axis may drive endothelial senescence.

Simplified

Cellular senescence plays a dual role in physiology and pathology. While it contributes to tumour suppression and tissue repair, its persistence promotes chronic inflammation, tissue dysfunction, and age-related diseases. Oxidative stress is a major driver of this process, and the RNA-binding protein HuR serves as a regulator by stabilizing transcripts encoding antioxidant and stress-response proteins. In this study, we established an in vitro model of replicative senescence using human umbilical vein endothelial cells (HUVECs) and investigated the potential anti-aging effects of N-acetylcysteine (NAC), an antioxidant and glutathione precursor. Late-passage HUVECs exhibited a senescent phenotype, including enlarged morphology, increased senescence-associated (SA)-β-galactosidase activity, elevated reactive oxygen species (ROS) levels, and upregulation of p16 and p21 proteins. We observed a progressive decline in HuR expression from early to late passages. NAC treatment counteracted these hallmarks, significantly decreasing ROS and p21 levels. Notably, NAC restored HuR expression and its protective targets, MnSOD and HSP70, and reduced inflammatory markers (IL-6 and TNF-α) levels. These findings suggest that the decline of the HuR-protective axis is a critical driver of endothelial senescence and demonstrate that NAC can mitigate aging hallmarks, representing a promising therapeutic strategy to target aging-related dysfunctions.

Full Text

Full text is available at the source.

View Full Text ↗

Using n-acetylcysteine to reduce cell aging in human blood vessel cells through the HuR pathway

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the longevity & aging brief